Current status of hepatic glycogen storage disease in Japan: clinical manifestations, treatments and long-term outcomes (Q46210619)

20 December 2017

title

Current status of hepatic glycogen storage disease in Japan: clinical manifestations, treatments and long-term outcomes (English)

1 reference

20 December 2017

main subject

glycogen storage disease

1 reference

9

Reiko Horikawa

1 reference

20 December 2017

author name string

Jun Kido

1

1 reference

20 December 2017

Kimitoshi Nakamura

2

1 reference

20 December 2017

Shirou Matsumoto

3

1 reference

20 December 2017

Hiroshi Mitsubuchi

4

1 reference

20 December 2017

Toshihiro Ohura

5

1 reference

20 December 2017

Yosuke Shigematsu

6

1 reference

20 December 2017

Tohru Yorifuji

7

1 reference

20 December 2017

Mureo Kasahara

8

1 reference

20 December 2017

Fumio Endo

10

1 reference

20 December 2017

publication date

14 March 2013

1 reference

20 December 2017

Journal of Human Genetics

published in

1 reference

20 December 2017

volume

58

1 reference

20 December 2017

issue

5

1 reference

20 December 2017

page(s)

285-292

1 reference

20 December 2017

Hepatorenal glycogenosis (type I glycogenosis) and carcinoma of the liver.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Hepatocellular carcinoma in glycogen storage disease type Ia: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Liver transplantation for type IV glycogen storage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

The natural history of liver glycogenosis due to phosphorylase kinase deficiency: a longitudinal study of 41 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

A novel starch for the treatment of glycogen storage diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

The benefits of liver transplantation in glycogenosis type Ib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Long-term outcome of liver transplantation in patients with glycogen storage disease type Ia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Long-term results of living donor liver transplantation for glycogen storage disorders in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Liver transplantation for glycogen storage disease types I, III, and IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

The long-term outcome of patients with glycogen storage diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Glycogen storage disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Long-term outcome and intervention of urea cycle disorders in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Glycogen storage disease type Ib: structural and mutational analysis of the microsomal glucose-6-phosphate transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Glycogen storage disease I and hepatocellular tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Transforming growth factor-beta in renal disease with glycogen storage disease I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Secondary diabetes mellitus: late complication of glycogen storage disease type 1b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Living donor liver transplantation for glycogen storage disease type Ib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk/benefit of this procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Outcomes of liver transplantation for glycogen storage disease: a matched-control study and a review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Liver transplantation for glycogen storage disease type Ia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

Renal disease in type I glycogen storage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

7 January 2021

Renal complications in glycogen storage disease type I

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

7 January 2021

Cardiac involvement in glycogen storage disease type III

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

7 January 2021

Fetal type IV glycogen storage disease: clinical, enzymatic, and genetic data of a pure muscular form with variable and early antenatal manifestations in the same family

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

7 January 2021

Fanconi-Bickel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

7 January 2021

Cornstarch therapy in type I glycogen-storage disease

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

7 January 2021

Catch-up growth in Fanconi-Bickel syndrome with uncooked cornstarch

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

7 January 2021

Efficacy of ACE-inhibitor therapy on renal disease in glycogen storage disease type 1: a multicentre retrospective study

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

7 January 2021

The long-term outcome of patients with glycogen storage disease type Ia

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

7 January 2021

Animal models of tyrosinemia

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

7 January 2021

Glucose-6-phosphatase gene mutations in 20 adult Japanese patients with glycogen storage disease type 1a with reference to hepatic tumors

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

7 January 2021

Metabolic control and renal dysfunction in type I glycogen storage disease

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

7 January 2021

Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemia

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

7 January 2021

Diabetes mellitus secondary to glycogen storage disease type III

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

7 January 2021

Outcome of living donor liver transplantation for glycogen storage disease

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2013.17

7 January 2021

Identifiers

DOI

10.1038/JHG.2013.17

1 reference

20 December 2017

1 reference

20 December 2017